Ajanta Pharma Ltd

Ajanta Pharma is primarily involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages.(Source : 201903 Annual Report Page No: 132)

  • Market Cap: 12,781 Cr.
  • Current Price: 1,465
  • 52 weeks High / Low 1580.00 / 825.00
  • Book Value: 297.83
  • Stock P/E: 27.17
  • Dividend Yield: 0.89 %
  • ROCE: 23.85 %
  • ROE: 18.06 %
  • Sales Growth (3Yrs): 5.52 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 2.00
Edit ratios
Pros:
Company is virtually debt free.
Company has a good return on equity (ROE) track record: 3 Years ROE 25.63%
Cons:
The company has delivered a poor growth of 11.21% over past five years.
Promoter holding has decreased over last 3 years: -3.27%

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
473 540 587 530 511 544 485 515 612 643 651 682
346 357 390 391 354 378 378 388 444 465 465 531
Operating Profit 127 184 198 140 157 166 107 127 168 178 186 151
OPM % 27% 34% 34% 26% 31% 31% 22% 25% 28% 28% 29% 22%
Other Income 5 9 15 5 8 15 4 2 8 12 14 54
Interest 0 0 0 0 0 0 0 1 2 5 2 4
Depreciation 13 15 15 17 17 17 19 19 23 23 24 26
Profit before tax 119 178 198 128 148 164 93 109 151 162 175 176
Tax % 20% 26% 25% 26% 29% 23% 28% 19% 24% 28% 39% 27%
Net Profit 95 132 147 94 106 125 67 89 115 116 108 129
EPS in Rs 10.77 14.99 16.76 10.74 12.02 14.25 7.60 10.10 13.14 13.34 12.33 14.80
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
309 349 409 498 677 931 1,208 1,474 1,749 1,983 2,126 2,055 2,588
257 284 330 409 545 706 840 969 1,161 1,292 1,467 1,489 1,905
Operating Profit 52 65 79 89 132 224 369 504 589 691 658 567 683
OPM % 17% 19% 19% 18% 19% 24% 31% 34% 34% 35% 31% 28% 26%
Other Income 1 2 1 10 6 6 14 9 20 20 24 21 88
Interest 16 24 20 18 15 19 9 6 5 1 0 1 12
Depreciation 8 14 21 25 32 34 44 52 44 61 60 72 96
Profit before tax 29 30 39 56 91 177 330 456 559 648 623 514 664
Tax % 24% 15% 12% 10% 15% 37% 29% 32% 26% 22% 25% 25%
Net Profit 22 25 34 51 77 112 234 310 416 507 469 387 468
EPS in Rs 2.41 2.81 3.76 5.61 8.55 6.18 25.79 13.77 46.99 57.30 52.98 44.12 53.61
Dividend Payout % 13% 12% 12% 12% 11% 13% 15% 17% 17% 23% 0% 20%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:19.40%
5 Years:11.21%
3 Years:5.52%
TTM:25.91%
Compounded Profit Growth
10 Years:31.31%
5 Years:10.61%
3 Years:-2.42%
TTM:21.58%
Stock Price CAGR
10 Years:50.51%
5 Years:-0.30%
3 Years:-2.14%
1 Year:46.23%
Return on Equity
10 Years:30.50%
5 Years:29.70%
3 Years:25.63%
Last Year:18.06%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
12 12 12 12 12 12 18 18 18 18 18 18 18
Reserves 123 145 173 217 286 382 576 823 1,173 1,550 2,024 2,228 2,581
Borrowings 174 250 228 191 200 125 130 72 81 1 2 36 73
52 52 82 103 151 200 226 233 207 254 383 383 647
Total Liabilities 360 459 495 522 649 718 949 1,146 1,479 1,823 2,426 2,664 3,319
102 138 168 214 246 273 279 288 451 589 1,053 1,179 1,472
CWIP 24 55 47 17 3 12 94 170 240 339 61 261 132
Investments 8 8 8 8 8 8 63 60 86 182 190 78 79
226 257 271 282 392 425 513 629 703 713 1,122 1,147 1,635
Total Assets 360 459 495 522 649 718 949 1,146 1,479 1,823 2,426 2,664 3,319

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
19 35 95 95 70 234 212 279 326 609 281 375
-59 -82 -43 -51 -53 -104 -188 -158 -209 -383 -256 -223
38 50 -46 -56 -13 -104 -20 -105 -117 -202 -0 -147
Net Cash Flow -2 2 7 -11 4 26 4 16 -0 24 25 5

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 17% 15% 14% 18% 23% 39% 55% 57% 52% 46% 34% 24%
Debtor Days 103 105 86 76 76 59 61 64 78 59 79 82
Inventory Turnover 1.71 1.29 1.25 1.58 1.64 1.92 2.28 2.32 2.28 2.00 1.45 0.98

Recent announcements

View all announcements

Annual reports

Credit ratings